207 related articles for article (PubMed ID: 32796875)
1. Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists.
Kaserer T; Steinacher T; Kainhofer R; Erli F; Sturm S; Waltenberger B; Schuster D; Spetea M
Sci Rep; 2020 Aug; 10(1):13804. PubMed ID: 32796875
[TBL] [Abstract][Full Text] [Related]
2. Progress in the development of more effective and safer analgesics for pain management.
Turnaturi R; Chiechio S; Salerno L; Rescifina A; Pittalà V; Cantarella G; Tomarchio E; Parenti C; Pasquinucci L
Eur J Med Chem; 2019 Dec; 183():111701. PubMed ID: 31550662
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking.
Dumitrascuta M; Bermudez M; Trovato O; De Neve J; Ballet S; Wolber G; Spetea M
Molecules; 2021 May; 26(11):. PubMed ID: 34071603
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Biased Mu-Opioid Receptor Agonists for the Treatment of Pain.
Ma M; Li X; Tong K; Cheng J; Yu Z; Ren F; Zhong B; Shi W
ChemMedChem; 2020 Jan; 15(1):155-161. PubMed ID: 31729174
[TBL] [Abstract][Full Text] [Related]
5. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
[TBL] [Abstract][Full Text] [Related]
7. Replacement of current opioid drugs focusing on MOR-related strategies.
Busserolles J; Lolignier S; Kerckhove N; Bertin C; Authier N; Eschalier A
Pharmacol Ther; 2020 Jun; 210():107519. PubMed ID: 32165137
[TBL] [Abstract][Full Text] [Related]
8. 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.
Zhang Y; Williams DA; Zaidi SA; Yuan Y; Braithwaite A; Bilsky EJ; Dewey WL; Akbarali HI; Streicher JM; Selley DE
ACS Chem Neurosci; 2016 Mar; 7(3):297-304. PubMed ID: 26716358
[TBL] [Abstract][Full Text] [Related]
9. Current strategies toward safer mu opioid receptor drugs for pain management.
Ehrlich AT; Kieffer BL; Darcq E
Expert Opin Ther Targets; 2019 Apr; 23(4):315-326. PubMed ID: 30802415
[TBL] [Abstract][Full Text] [Related]
10. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
Kruegel AC; Gassaway MM; Kapoor A; Váradi A; Majumdar S; Filizola M; Javitch JA; Sames D
J Am Chem Soc; 2016 Jun; 138(21):6754-64. PubMed ID: 27192616
[TBL] [Abstract][Full Text] [Related]
11. Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects.
Kandasamy R; Hillhouse TM; Livingston KE; Kochan KE; Meurice C; Eans SO; Li MH; White AD; Roques BP; McLaughlin JP; Ingram SL; Burford NT; Alt A; Traynor JR
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846240
[TBL] [Abstract][Full Text] [Related]
12. A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.
Lei W; Vekariya RH; Ananthan S; Streicher JM
J Pain; 2020; 21(1-2):146-160. PubMed ID: 31201990
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D
Bonifazi A; Saab E; Sanchez J; Nazarova AL; Zaidi SA; Jahan K; Katritch V; Canals M; Lane JR; Newman AH
J Med Chem; 2023 Aug; 66(15):10304-10341. PubMed ID: 37467430
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
Chen SL; Ma HI; Han JM; Lu RB; Tao PL; Law PY; Loh HH
J Biomed Sci; 2010 Apr; 17(1):28. PubMed ID: 20403204
[TBL] [Abstract][Full Text] [Related]
15. Designing safer analgesics: a focus on μ-opioid receptor pathways.
Pergolizzi JV; LeQuang JA; Taylor R; Ossipov MH; Colucci D; Raffa RB
Expert Opin Drug Discov; 2018 Oct; 13(10):965-972. PubMed ID: 30175624
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability.
Crowley RS; Riley AP; Sherwood AM; Groer CE; Shivaperumal N; Biscaia M; Paton K; Schneider S; Provasi D; Kivell BM; Filizola M; Prisinzano TE
J Med Chem; 2016 Dec; 59(24):11027-11038. PubMed ID: 27958743
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation.
Jiang X; Li S; Zhang H; Wang LL
Comput Biol Chem; 2021 Feb; 90():107405. PubMed ID: 33184004
[TBL] [Abstract][Full Text] [Related]
19. Novel Opioid Receptor Agonists with Reduced Morphine-like Side Effects.
Zhu L; Cui Z; Zhu Q; Zha X; Xu Y
Mini Rev Med Chem; 2018; 18(19):1603-1610. PubMed ID: 30009707
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional μ opioid and σ
Zhuang T; Xiong J; Hao S; Du W; Liu Z; Liu B; Zhang G; Chen Y
Eur J Med Chem; 2021 Nov; 223():113658. PubMed ID: 34175542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
